SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: John Hensley who wrote (7148)4/1/1998 6:00:00 PM
From: Jody Ritchie  Read Replies (2) | Respond to of 8116
 
Dammit!!!! Where is CYTO PR?

I thought I saw them turning the corner with their crappy PR, but I was obviously mistaken.

This is great news and CYTO is not capitalizing on it.

NOTE to Bags: It's not just cutting costs, it's selling products and marketing your company!

Jody



To: John Hensley who wrote (7148)4/6/1998 11:36:00 AM
From: John Hensley  Read Replies (2) | Respond to of 8116
 
I was listening to G. Gordon Liddy and he read a story out of the Washington Times, I guess out of the Journal of Oncology, regarding Quadramet and its effectivenes.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News